March 1, 2017 | Daily JAM, Morning Briefing |
Wall Street heard what it wanted to hear from President Donald Trump in his address to a joint session of Congress last night. Or to be more precise it didn’t hear anything it didn’t want to hear. Trump waved in the direction of cutting regulations, repealing Obamacare, cutting taxes, and spending more on the military, education, and infrastructure.
February 25, 2017 | Short Term |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
February 24, 2017 | Uncategorized |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
February 18, 2017 | Uncategorized |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
January 22, 2017 | Daily JAM |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
January 17, 2017 | Daily JAM, Morning Briefing |
The U.S. dollar fell today after President-elect Donald Trump told the Wall Street Journal that the U.S. currency was too high–in part because China holds down the price of the yuan. On the comments the Bloomberg Dollar Spot Index was down 1.1% as of noon New York time.
January 16, 2017 | Daily JAM, Morning Briefing, Short Term |
In an interview with the London Times and Germany’s Bild President-elect Donald Trump managed to dismiss the European Union as a tool for expanding German exports and to label NATO as obsolete. Shares of German automakers and British pound are hit
December 29, 2016 | Daily JAM, SFTBY, Stock Alerts |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
December 15, 2016 | Daily JAM, Morning Briefing |
Yesterday the director of Beijing’s National Development and Reform Commission’s price supervision bureau told the state-run China Daily that its investigators had found evidence that a U.S. carmaker has been telling its dealers to fix prices since 2014. Accusations like this can end in sizable fines and other penalties. You think that it’s just a coincidence that this charge comes after President-elect Donald Trump has ramped up his rhetoric about branding China a currency manipulator?
December 13, 2016 | Daily JAM, Mid Term |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
December 7, 2016 | Daily JAM, Short Term, Volatility |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
December 7, 2016 | Daily JAM, Morning Briefing |
“I’m going to bring down drug prices. I don’t like what’s happened with drug prices,” President-elect Donald Trump said in an interview with Time posted on the magazine’s website this morning. So much, the stock market has concluded today, for the idea that a President Trump would be friendlier than a President Clinton to the drug industry.
